Gwendolyn Wright
Gerontology · Grand Blanc, MINPI 1467832246
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 31.1% of the total. 2025 is the largest year on record at $25,139, more than ten times the $1,240 reported in 2021. Among gerontology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 390 payments — averaging $120.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$15K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$14K
- AbbVie$11K
- Sanofi$3K
- Ipsen Biopharmaceuticals, Inc$1K
- Johnson & Johnson$502
- plus $3K from 24 others
What the payments were for
- Consulting fees$7,41616%
- Speaking & faculty fees$21,74046%
- Travel & lodging$7,56316%
- Food & beverage$9,98421%
- Education$1120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 60 | $14,580 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 92 | $13,546 |
| AbbVie | 104 | $11,217 |
| Sanofi | 12 | $3,114 |
| Ipsen Biopharmaceuticals, Inc | 11 | $1,254 |
| Johnson & Johnson | 18 | $502 |
| Regeneron Healthcare Solutions, Inc. | 12 | $338 |
| Gilead | 16 | $329 |
| Pfizer | 11 | $297 |
| Regeneron | 2 | $232 |
| Ardelyx, Inc. | 7 | $211 |
| Intercept Pharmaceuticals, Inc. | 4 | $165 |
| Lilly USA, LLC | 7 | $138 |
| E.r. Squibb & Sons, L.L.C. | 1 | $100 |
| Phathom Pharmaceuticals, Inc. | 5 | $92 |
| Madrigal Pharmaceuticals | 1 | $84 |
| Celltrion USA Inc. | 4 | $83 |
| Janssen Scientific Affairs, LLC | 1 | $76 |
| Merz North America, Inc. | 2 | $74 |
| Organon | 3 | $63 |
| Aimmune Therapeutics, Inc. | 3 | $61 |
| Bristol Myers Squibb | 3 | $53 |
| Ferring Pharmaceuticals Inc. | 2 | $53 |
| Ironwood Pharmaceuticals, Inc | 3 | $48 |
| Nestle Healthcare Nutrition Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Intra-sana Laboratories | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$46,814 in reported general payments places this provider in the 95th percentile of 279 gerontology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 157 | $119,910 |
| CreonLipase/Protease/Amylase | 21 | $68,590 |
| XifaxanRifaximin | 20 | $59,857 |
| Mesalamine | 18 | $20,183 |
| ViberziEluxadoline | 11 | $15,043 |
| MotegrityPrucalopride Succinate | 18 | $14,947 |
| Lubiprostone | 102 | $13,394 |
| Colestipol Hcl | 37 | $3,282 |
| Mesalamine DrMesalamine | 12 | $3,214 |
| Omeprazole | 246 | $2,776 |
| Budesonide DrBudesonide | 25 | $2,148 |
| Pantoprazole Sodium | 101 | $1,736 |
| Rabeprazole Sodium | 59 | $1,681 |
| Budesonide EcBudesonide | 15 | $1,655 |
| Dicyclomine Hcl | 78 | $1,612 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon, Viberzi | $11,217 | $203,543189 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $13,546 | $59,85720 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $14,580 | $14,94718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 279 gerontology providers in Michigan.
Other gerontology in Grand Blanc
- Theresa JensenGrand Blanc$4K
- Matthew AmanRochester Hills$21K
- Sarah ArnkoffWest Bloomfield$18K
- Deborah GriffinPetoskey$11K
- Angela EmbreeGrand Rapids$10K
- Bethany DalessandroWyandotte$10K
- Gabrielle NadeauJackson$10K
- Cynthera McNeillWest Bloomfield$9K
- Samantha BurgessGrand Rapids$9K
- Joanna HernandezWarren$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.